ABN AMRO Investment Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
ABN AMRO Investment Solutions's BMY Position: Q2 2026 in Review
ABN AMRO Investment Solutions increased its Bristol-Myers Squibb (BMY) stake by 32% in Q2 2026, buying an estimated $2.03M and bringing the position to 147,546 shares worth $8.5M. The position accounts for 0.07% of the portfolio, ranked #175.
ABN AMRO Investment Solutions first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. 830 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- ABN AMRO Investment Solutions held 147,546 shares of Bristol-Myers Squibb worth $8.5M as of Q2 2026.
- ABN AMRO Investment Solutions bought 35,415 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.03M.
- Bristol-Myers Squibb made up 0.07% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #175 holding.
- ABN AMRO Investment Solutions first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
- 830 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.